<DOC>
	<DOC>NCT01014325</DOC>
	<brief_summary>The objective of this clinical trial is to assess the safety and efficacy of sublingual application of allergen extracts for specific immunotherapy in patients suffering from perennial allergic rhinitis due to house dust mites.</brief_summary>
	<brief_title>Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Positive history of perennial allergic rhinitis Positive screening skin prick test (wheal diameter &gt; 3 mm) Compliance and ability of the patient to complete a Diary Card for selfevaluating of the symptoms and antisymptomatic medication Signed and dated patient´s Informed Consent, Previous immunotherapy with allergen extracts within the last 3 years, Simultaneous participation in other clinical trials, Other reasons contraindicating an inclusion into the trial according to the investigator´s estimation (e.g. poor compliance), Autoimmune disorders, Severe chronic inflammatory diseases, Malignancy, Alcohol abuse, Existing or intended pregnancy, lactation and/or lack of adequate contraceptive protection, Treatment with betablockers (incl. local application) and/or other contraindicated drugs.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>